Is a guidance cut confirmed after this miss?

Not yet confirmed — management must address this on the July 29 call. However, the H1 run-rate annualizes below the guidance floor, making reaffirmation without credible H2 acceleration catalysts difficult to sustain.

Can I trade TDOC CFDs right now, given earnings were after NYSE close?

Yes — CoinUnited's stock CFDs trade 24/7, so TDOC can be traded immediately after the after-hours earnings release without waiting for the NYSE 9:30am ET open.

Which other stocks could see read-through selling from this miss?

DTC telehealth and digital health peers with similar consumer-facing mental health or virtual care exposure are most at risk of sympathy selling. Zoom Video Communications, which has overlapping virtual care narratives, is one cross-market name to watch.

What leverage considerations apply to trading a post-earnings gap like this?

Post-earnings gaps can be sharp and fast-moving — elevated implied volatility and wide bid-ask spreads are common in the first hour. Position sizing relative to leverage level is critical; monitor for any follow-through guidance commentary before adding exposure.

त्वरित लिंक

Teladoc Q2 2026 Revenue Slides 4% YoY — BetterHelp Drag Deepens the Miss

प्रकाशित: 2026-07-29 23:03:30 UTC

डेटा स्नैपशॉट

Net Loss

$38.9M (-$0.21/share)

Q2 2026 Revenue

$606.9M (-4% YoY)

BetterHelp Revenue

$212.6M (-12% YoY)

FY2026 Revenue Guidance

$2.48B–$2.58B

Integrated Care Revenue

$394.3M (+1% YoY)

Q2 2026 Adjusted EBITDA

$65.7M (-5% YoY)

मुख्य निष्कर्ष

•Teladoc Q2 2026 revenue of $606.9M declined 4% YoY — steeper than the -1.6% in Q2 2025 — with adjusted EBITDA down 5% YoY to $65.7M.
•BetterHelp is the core problem: -12% YoY revenue and a 0.2% EBITDA margin signal the DTC mental health thesis remains structurally challenged.
•Combined Q1+Q2 run-rate of ~$610M/quarter annualizes to ~$2.44B, below the low end of 2026 guidance ($2.48B–$2.58B) — a guidance cut is a live risk.
•TDOC stock CFDs are tradeable 24/7 on CoinUnited, allowing immediate positioning after the after-hours earnings call without waiting for NYSE open.
•Sector read-through is negative for DTC telehealth and digital health ETFs; Integrated Care's +1% growth and 16.5% margin is the lone relative positive.

The NASDAQ 100 Index (US100) opened at 27,606.0 and closed at 27,331.6, reflecting a decline of 0.99% over the last 24 hours. The index reached a high of 28,023.3 and a low of 27,030.5 during this period. In comparison, the S&P 500 Index (US500) experienced a larger drop of 1.06%, while Zoom Video Communications (ZM) showed a positive change of 1.45%. This indicates that while the NASDAQ 100 faced a slight downturn, Zoom was a notable outperformer amidst the broader market decline. The overall sentiment appears bearish, particularly for the indices, with Teladoc's revenue miss contributing to market volatility. — NASDAQ 100 Index closed down 0.99% at 27,331.6 amid broader market declines.

Teladoc Health, Inc. reported Q2 2026 results on July 29, 2026, confirming what markets feared: consolidated revenue of $606.9 million, down 4% year-over-year, with adjusted EBITDA of $65.7 million, a

Event Analysis

Teladoc Health, Inc. reported Q2 2026 results on July 29, 2026, confirming what markets feared: consolidated revenue of $606.9 million, down 4% year-over-year, with adjusted EBITDA of $65.7 million, also down 5% YoY, and a net loss of $38.9 million (-$0.21 per share), according to the company's official GlobeNewswire press release. The deterioration is steeper than Q2 2025's -1.6% YoY decline, marking a clear acceleration in the wrong direction.

The culprit is BetterHelp, Teladoc's direct-to-consumer therapy unit, which posted $212.6 million in revenue (-12% YoY) at a near-zero 0.2% adjusted EBITDA margin — essentially breakeven despite prior management promises of scaling insurance-covered sessions toward $125M+ annualized by year-end. The Integrated Care B2B segment held up comparatively, growing +1% YoY to $394.3 million with a healthy 16.5% EBITDA margin, but cannot offset the structural drag from BetterHelp.

The strategic significance here is narrative collapse. Teladoc was once priced as a high-growth DTC mental health and virtual care platform. What Q2 2026 reveals is a bifurcated business: a slow-growth but viable enterprise segment, and a cash-burning consumer segment with deteriorating unit economics. This is a classic earnings miss revenue shock scenario where the headline miss compounds existing skepticism about the DTC telehealth model broadly.

An annualization of the Q1 ($614M) and Q2 ($607M) run-rate implies roughly $2.44B in annual revenue — below the low end of management's full-year 2026 guidance of $2.48B–$2.58B. Teladoc now needs a meaningful H2 acceleration to avoid a guidance cut, making every word of the earnings call transcript alpha-critical. Traders watching the earnings miss deep dive playbook will know: guidance cuts post-miss are the second shoe to drop.

What This Means for Traders

The immediate trading implication for TDOC is bearish. The earnings call was after hours on July 29, meaning traders using CoinUnited's stock CFDs — which trade 24/7 — can position on TDOC without waiting for the next NYSE session open. Historical precedent is instructive: Q2 2024 earnings triggered an approximately 9.8% single-session drawdown. A comparable or larger move is plausible given the accelerating YoY revenue decline and BetterHelp's near-zero margins.

For the broader sector, Teladoc functions as a bellwether for public virtual care and DTC mental health names. Weakness here can pressure digital health-focused ETFs and comparable telehealth peers, including Zoom Video Communications (which has telehealth and virtual care exposure). Sentiment read-through is risk-off for high-beta digital health. Traders should monitor whether any guidance revision on the call reopens the valuation debate — a confirmed cut would likely extend selling into subsequent sessions, fitting the earnings miss sector contagion pattern. Broad indices like the S&P 500 and NASDAQ-100 face negligible direct impact given Teladoc's small index weight, but thematic rotation away from unprofitable growth names could contribute marginally to sector-level pressure.

Start Trading on CoinUnited.io

Create Your Free Account → — Trade crypto, stocks, forex, indices, and commodities with up to 2000x leverage and zero fees.

अक्सर पूछे जाने वाले प्रश्न

At 0.2% EBITDA margin and -12% YoY revenue, BetterHelp is consuming management bandwidth for near-zero return — the earnings call transcript will be key for any signals on restructuring, partnerships, or asset review. Historically, businesses at this margin level become strategic review candidates within 2–4 quarters if trajectory doesn't improve.